KZR
Kezar Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.29
+0.00%Leverage
- Debt / equity
- 0.02x
- Net debt / equity
- -0.99x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.03x
- Net debt / EBITDA
- 1.66x
Liquidity & coverage
- Current ratio
- 24.46x
- Quick ratio
- 24.46x
- Cash ratio
- 23.98x
- Interest coverage
- -50.01x
- EBITDA / interest
- -46.59x
- Working capital
- $64.8M
Cash & dividend
- FCF / debt
- -31.04x
- Cash flow / debt
- -31.04x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026